Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02073747 · ClinicalTrials.gov registry record · NA
The Various Effects of Gaseous Albuterol on Serum Lactate
A NA study, sponsored by University Medical Center of Southern Nevada.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02073747 is a NA study that has completed, run by University Medical Center of Southern Nevada. The registered enrollment target is 28 participants.
The verdict
NCT02073747, a NA study, has completed, sponsored by University Medical Center of Southern Nevada.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Empirical data from physician observation indicates an increase in serum lactate in acute asthmatic patients being treated with inhaled albuterol therapy. It is not clear if this increased serum lactate is in response to a physiological response to the asthmatic process or from the albuterol treatment. This study is designed to determine if administration of inhaled albuterol increases serum lactate in healthy subjects.
Interventions
- DRUG Normal Saline
- DRUG Albuterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02073747
The ClinicalTrials.gov registry entry for NCT02073747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Medical Center of Southern Nevada, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT02073747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02073747 about?
NCT02073747 is a clinical study titled "The Various Effects of Gaseous Albuterol on Serum Lactate". Empirical data from physician observation indicates an increase in serum lactate in acute asthmatic patients being treated with inhaled albuterol therapy. It is not clear if this increased serum lactate is in response to a physiological response to the asthmatic process or from the albuterol treatm...
What is the current status of trial NCT02073747?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-04. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02073747?
The interventions under investigation include: Normal Saline (DRUG), Albuterol (DRUG).
Who is sponsoring clinical trial NCT02073747?
This trial is sponsored by University Medical Center of Southern Nevada, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.